JP2018516884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516884A5 JP2018516884A5 JP2017557988A JP2017557988A JP2018516884A5 JP 2018516884 A5 JP2018516884 A5 JP 2018516884A5 JP 2017557988 A JP2017557988 A JP 2017557988A JP 2017557988 A JP2017557988 A JP 2017557988A JP 2018516884 A5 JP2018516884 A5 JP 2018516884A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- heterocyclyl
- alkyl
- composition according
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- 125000001072 heteroaryl group Chemical group 0.000 claims 15
- 125000000623 heterocyclic group Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 239000001257 hydrogen Substances 0.000 claims 14
- 125000003342 alkenyl group Chemical group 0.000 claims 9
- 125000000304 alkynyl group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000004452 carbocyclyl group Chemical group 0.000 claims 9
- 150000002431 hydrogen Chemical class 0.000 claims 8
- -1 amino, hydroxyl Chemical group 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- 239000000090 biomarker Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 239000003112 inhibitor Substances 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 101000931374 Homo sapiens Zinc finger protein ZFPM1 Proteins 0.000 claims 3
- 102100020993 Zinc finger protein ZFPM1 Human genes 0.000 claims 3
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 2
- 108091012583 BCL2 Proteins 0.000 claims 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 claims 2
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims 2
- 102100032912 CD44 antigen Human genes 0.000 claims 2
- 108091011896 CSF1 Proteins 0.000 claims 2
- 102100025176 Cyclin-A1 Human genes 0.000 claims 2
- 102100031785 Endothelial transcription factor GATA-2 Human genes 0.000 claims 2
- 102100031690 Erythroid transcription factor Human genes 0.000 claims 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 claims 2
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 2
- 101000934314 Homo sapiens Cyclin-A1 Proteins 0.000 claims 2
- 101001066265 Homo sapiens Endothelial transcription factor GATA-2 Proteins 0.000 claims 2
- 101001066268 Homo sapiens Erythroid transcription factor Proteins 0.000 claims 2
- 101001062996 Homo sapiens Friend leukemia integration 1 transcription factor Proteins 0.000 claims 2
- 101000598002 Homo sapiens Interferon regulatory factor 1 Proteins 0.000 claims 2
- 101001032345 Homo sapiens Interferon regulatory factor 8 Proteins 0.000 claims 2
- 101000652382 Homo sapiens O-phosphoseryl-tRNA(Sec) selenium transferase Proteins 0.000 claims 2
- 101000876829 Homo sapiens Protein C-ets-1 Proteins 0.000 claims 2
- 101000893493 Homo sapiens Protein flightless-1 homolog Proteins 0.000 claims 2
- 101000994437 Homo sapiens Protein jagged-1 Proteins 0.000 claims 2
- 101001111742 Homo sapiens Rhombotin-2 Proteins 0.000 claims 2
- 101000689199 Homo sapiens Src-like-adapter Proteins 0.000 claims 2
- 101000891113 Homo sapiens T-cell acute lymphocytic leukemia protein 1 Proteins 0.000 claims 2
- 101001023770 Homo sapiens Transcription factor NF-E2 45 kDa subunit Proteins 0.000 claims 2
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims 2
- 102100036981 Interferon regulatory factor 1 Human genes 0.000 claims 2
- 102100038069 Interferon regulatory factor 8 Human genes 0.000 claims 2
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 2
- 102100035251 Protein C-ets-1 Human genes 0.000 claims 2
- 102100040923 Protein flightless-1 homolog Human genes 0.000 claims 2
- 102100032702 Protein jagged-1 Human genes 0.000 claims 2
- 102100023876 Rhombotin-2 Human genes 0.000 claims 2
- 101000702553 Schistosoma mansoni Antigen Sm21.7 Proteins 0.000 claims 2
- 101000714192 Schistosoma mansoni Tegument antigen Proteins 0.000 claims 2
- 101150045565 Socs1 gene Proteins 0.000 claims 2
- 102100024519 Src-like-adapter Human genes 0.000 claims 2
- 108700027336 Suppressor of Cytokine Signaling 1 Proteins 0.000 claims 2
- 102100024779 Suppressor of cytokine signaling 1 Human genes 0.000 claims 2
- 102100040365 T-cell acute lymphocytic leukemia protein 1 Human genes 0.000 claims 2
- 102100035412 Transcription factor NF-E2 45 kDa subunit Human genes 0.000 claims 2
- 102100040247 Tumor necrosis factor Human genes 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 102000017920 ADRB1 Human genes 0.000 claims 1
- 102100032898 AMP deaminase 3 Human genes 0.000 claims 1
- 102100035984 Adenosine receptor A2b Human genes 0.000 claims 1
- 102100021038 Arrestin domain-containing protein 4 Human genes 0.000 claims 1
- 102100021334 Bcl-2-related protein A1 Human genes 0.000 claims 1
- 102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 claims 1
- 102100031974 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Human genes 0.000 claims 1
- 101100227322 Caenorhabditis elegans fli-1 gene Proteins 0.000 claims 1
- 102100024490 Cdc42 effector protein 3 Human genes 0.000 claims 1
- 101150090188 Cdk8 gene Proteins 0.000 claims 1
- 108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 claims 1
- 102100035300 Cystine/glutamate transporter Human genes 0.000 claims 1
- 102100028183 Cytohesin-interacting protein Human genes 0.000 claims 1
- 102100032218 Cytokine-inducible SH2-containing protein Human genes 0.000 claims 1
- 101100107081 Danio rerio zbtb16a gene Proteins 0.000 claims 1
- 102100037569 Dual specificity protein phosphatase 10 Human genes 0.000 claims 1
- 101150031329 Ets1 gene Proteins 0.000 claims 1
- 108010013942 GMP Reductase Proteins 0.000 claims 1
- 102100021188 GMP reductase 1 Human genes 0.000 claims 1
- 102100022898 Galactoside-binding soluble lectin 13 Human genes 0.000 claims 1
- 101150023475 Gfi1 gene Proteins 0.000 claims 1
- 102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 claims 1
- 101000797462 Homo sapiens AMP deaminase 3 Proteins 0.000 claims 1
- 101000783756 Homo sapiens Adenosine receptor A2b Proteins 0.000 claims 1
- 101000784133 Homo sapiens Arrestin domain-containing protein 4 Proteins 0.000 claims 1
- 101000894929 Homo sapiens Bcl-2-related protein A1 Proteins 0.000 claims 1
- 101000892264 Homo sapiens Beta-1 adrenergic receptor Proteins 0.000 claims 1
- 101000914211 Homo sapiens CASP8 and FADD-like apoptosis regulator Proteins 0.000 claims 1
- 101000703754 Homo sapiens CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 Proteins 0.000 claims 1
- 101000762414 Homo sapiens Cdc42 effector protein 3 Proteins 0.000 claims 1
- 101000916686 Homo sapiens Cytohesin-interacting protein Proteins 0.000 claims 1
- 101000943420 Homo sapiens Cytokine-inducible SH2-containing protein Proteins 0.000 claims 1
- 101000881127 Homo sapiens Dual specificity protein phosphatase 10 Proteins 0.000 claims 1
- 101000620927 Homo sapiens Galactoside-binding soluble lectin 13 Proteins 0.000 claims 1
- 101000878611 Homo sapiens High affinity immunoglobulin epsilon receptor subunit alpha Proteins 0.000 claims 1
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims 1
- 101001044929 Homo sapiens Interactor protein for cytohesin exchange factors 1 Proteins 0.000 claims 1
- 101000799318 Homo sapiens Long-chain-fatty-acid-CoA ligase 1 Proteins 0.000 claims 1
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 claims 1
- 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 claims 1
- 101000764294 Homo sapiens Lymphotoxin-beta Proteins 0.000 claims 1
- 101000884270 Homo sapiens Natural killer cell receptor 2B4 Proteins 0.000 claims 1
- 101000873418 Homo sapiens P-selectin glycoprotein ligand 1 Proteins 0.000 claims 1
- 101000986836 Homo sapiens P2Y purinoceptor 2 Proteins 0.000 claims 1
- 101001131972 Homo sapiens PX domain-containing protein kinase-like protein Proteins 0.000 claims 1
- 101001000631 Homo sapiens Peripheral myelin protein 22 Proteins 0.000 claims 1
- 101001082860 Homo sapiens Peroxisomal membrane protein 2 Proteins 0.000 claims 1
- 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 claims 1
- 101000691480 Homo sapiens Placenta-specific gene 8 protein Proteins 0.000 claims 1
- 101000582936 Homo sapiens Pleckstrin Proteins 0.000 claims 1
- 101001094872 Homo sapiens Plexin-C1 Proteins 0.000 claims 1
- 101000898093 Homo sapiens Protein C-ets-2 Proteins 0.000 claims 1
- 101001103597 Homo sapiens RING finger protein 24 Proteins 0.000 claims 1
- 101000620773 Homo sapiens Ras GTPase-activating protein 3 Proteins 0.000 claims 1
- 101000606535 Homo sapiens Receptor-type tyrosine-protein phosphatase epsilon Proteins 0.000 claims 1
- 101001093899 Homo sapiens Retinoic acid receptor RXR-alpha Proteins 0.000 claims 1
- 101001094537 Homo sapiens Retrotransposon Gag-like protein 3 Proteins 0.000 claims 1
- 101000666634 Homo sapiens Rho-related GTP-binding protein RhoH Proteins 0.000 claims 1
- 101000661819 Homo sapiens Serine/threonine-protein kinase 17B Proteins 0.000 claims 1
- 101100314013 Homo sapiens TMEM158 gene Proteins 0.000 claims 1
- 101000596334 Homo sapiens TSC22 domain family protein 1 Proteins 0.000 claims 1
- 101000596277 Homo sapiens TSC22 domain family protein 3 Proteins 0.000 claims 1
- 101001041525 Homo sapiens Transcription factor 12 Proteins 0.000 claims 1
- 101000866298 Homo sapiens Transcription factor E2F8 Proteins 0.000 claims 1
- 101001004913 Homo sapiens Transforming growth factor beta activator LRRC33 Proteins 0.000 claims 1
- 101000852847 Homo sapiens Transmembrane protein 104 Proteins 0.000 claims 1
- 101000838097 Homo sapiens Transmembrane protein 121B Proteins 0.000 claims 1
- 101000801088 Homo sapiens Transmembrane protein 201 Proteins 0.000 claims 1
- 101001000116 Homo sapiens Unconventional myosin-Ig Proteins 0.000 claims 1
- 101100377226 Homo sapiens ZBTB16 gene Proteins 0.000 claims 1
- 101000856554 Homo sapiens Zinc finger protein Gfi-1b Proteins 0.000 claims 1
- 101000991029 Homo sapiens [F-actin]-monooxygenase MICAL2 Proteins 0.000 claims 1
- 108010000775 Hydroxymethylglutaryl-CoA synthase Proteins 0.000 claims 1
- 102100028888 Hydroxymethylglutaryl-CoA synthase, cytoplasmic Human genes 0.000 claims 1
- 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 claims 1
- 108090000957 Insulin-like growth factor-binding protein 1 Proteins 0.000 claims 1
- 102000004369 Insulin-like growth factor-binding protein 4 Human genes 0.000 claims 1
- 108090000969 Insulin-like growth factor-binding protein 4 Proteins 0.000 claims 1
- 102100032816 Integrin alpha-6 Human genes 0.000 claims 1
- 102100022711 Interactor protein for cytohesin exchange factors 1 Human genes 0.000 claims 1
- 102100038204 Large neutral amino acids transporter small subunit 1 Human genes 0.000 claims 1
- 102100033995 Long-chain-fatty-acid-CoA ligase 1 Human genes 0.000 claims 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 claims 1
- 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 claims 1
- 102100026894 Lymphotoxin-beta Human genes 0.000 claims 1
- 108700012912 MYCN Proteins 0.000 claims 1
- 101150022024 MYCN gene Proteins 0.000 claims 1
- 102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 claims 1
- 101100281205 Mus musculus Fli1 gene Proteins 0.000 claims 1
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 claims 1
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 claims 1
- 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims 1
- 108090000772 Neuropilin-1 Proteins 0.000 claims 1
- 102000001756 Notch2 Receptor Human genes 0.000 claims 1
- 108010029751 Notch2 Receptor Proteins 0.000 claims 1
- 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims 1
- 102100028045 P2Y purinoceptor 2 Human genes 0.000 claims 1
- 102100034602 PX domain-containing protein kinase-like protein Human genes 0.000 claims 1
- 102100030564 Peroxisomal membrane protein 2 Human genes 0.000 claims 1
- 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 claims 1
- 102100030264 Pleckstrin Human genes 0.000 claims 1
- 102100035381 Plexin-C1 Human genes 0.000 claims 1
- 108700003766 Promyelocytic Leukemia Zinc Finger Proteins 0.000 claims 1
- 102100021890 Protein C-ets-2 Human genes 0.000 claims 1
- 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 claims 1
- 102100039516 RING finger protein 24 Human genes 0.000 claims 1
- 102100022879 Ras GTPase-activating protein 3 Human genes 0.000 claims 1
- 102100039767 Ras-related protein Rab-27A Human genes 0.000 claims 1
- 102100039665 Receptor-type tyrosine-protein phosphatase epsilon Human genes 0.000 claims 1
- 102100020981 Regulator of G-protein signaling 16 Human genes 0.000 claims 1
- 101710148341 Regulator of G-protein signaling 16 Proteins 0.000 claims 1
- 102100035178 Retinoic acid receptor RXR-alpha Human genes 0.000 claims 1
- 102100035122 Retrotransposon Gag-like protein 3 Human genes 0.000 claims 1
- 102100038338 Rho-related GTP-binding protein RhoH Human genes 0.000 claims 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 claims 1
- 108091006241 SLC7A11 Proteins 0.000 claims 1
- 108091006232 SLC7A5 Proteins 0.000 claims 1
- 102100037959 Serine/threonine-protein kinase 17B Human genes 0.000 claims 1
- 101000987219 Sus scrofa Pregnancy-associated glycoprotein 1 Proteins 0.000 claims 1
- 102100035051 TSC22 domain family protein 1 Human genes 0.000 claims 1
- 102100035260 TSC22 domain family protein 3 Human genes 0.000 claims 1
- 108010031429 Tissue Inhibitor of Metalloproteinase-3 Proteins 0.000 claims 1
- 102100021123 Transcription factor 12 Human genes 0.000 claims 1
- 102100031555 Transcription factor E2F8 Human genes 0.000 claims 1
- 102100025954 Transforming growth factor beta activator LRRC33 Human genes 0.000 claims 1
- 102100036722 Transmembrane protein 104 Human genes 0.000 claims 1
- 102100028600 Transmembrane protein 121B Human genes 0.000 claims 1
- 102100033036 Transmembrane protein 158 Human genes 0.000 claims 1
- 102100033708 Transmembrane protein 201 Human genes 0.000 claims 1
- 102100035824 Unconventional myosin-Ig Human genes 0.000 claims 1
- 102100040314 Zinc finger and BTB domain-containing protein 16 Human genes 0.000 claims 1
- 102100025531 Zinc finger protein Gfi-1b Human genes 0.000 claims 1
- 102100030295 [F-actin]-monooxygenase MICAL2 Human genes 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000007789 gas Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- 108010033990 rab27 GTP-Binding Proteins Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
Claims (15)
- 抗CDK8/19療法に応答する腫瘍又は癌を有する患者を治療するための医薬組成物であって、
CDK8/19阻害剤、又はその薬学的に許容可能な塩若しくはオキシドを含み、
前記患者は、RUNX1経路障害を有し、
前記阻害剤は、式:
R 1 及びR 2 は接合してヘテロシクリル又はヘテロアリールを形成し、ヘテロシクリル及びヘテロアリールの各々は、1つ以上のR 7 基で任意に置換されていてもよく;
R 3 は、水素又はアルキルであり;
R 4 は、水素、ハロゲン、アルキル、又は−Si(R A ) 3 であり;
R 5A は、水素、ハロゲン、アルキル、又は−OR A であり;
(a)、(b)、及び(c)として指定される、
a.(c)として指定される、
b.(c)として指定される、
R B1 及びR B2 の各々は、独立して、水素、−L 1 −R B3 、又は−X A R A であるか;あるいは
R B1 及びR B2 は接合してオキソ基を形成しており;
X A は、−O−、−S−、又は−N(R A )−であり;
L 1 は、結合、−CH(CH 3 )(CH 2 ) 2 −、−CH(CH 3 )−CH=CH−、−C(=O)−、−C(=O)O−、−C(=O)S−、−C(=O)N(R L )−、又は−N(R L )−(C(R LL ) 2 ) p −であり;
R L は、水素又はアルキルであり;
R LL の各々は、独立して、水素、ハロゲン、又はアルキルであり;
pは、0、1、又は2であり;
R B3 は、水素、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又は任意に置換されたヘテロアリールであり(但し、L 1 が結合であるとき、R B3 は水素ではない);
R A の各々は、独立して、水素、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、ヘテロアリール、カルボニル、又はシリルであり;2つのR A 基が任意にNに結合するとき、2つのR A 基は接合してヘテロシクリル又はヘテロアリール環を形成していてもよく;
R 7 の各々は、独立して、ハロゲン、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、ヘテロアリール、アミノ、ヒドロキシル、又はチオールである)
で表される、医薬組成物。 - R 3 が−CH 3 である、請求項1に記載の医薬組成物。
- R 4 が水素である、請求項1に記載の医薬組成物。
- R 5 が水素である、請求項1に記載の医薬組成物。
- (a)及び(b)として指定される、
- (c)として指定される、
- 前記阻害剤が、式:
R 6A の各々は、独立して、ハロゲン、−NO 2 、−CN、−OR 6C 、SR 6C 、N(R 6C ) 2 、−C(=O)R 6C 、−C(=O)OR 6C 、−C(=O)N(R 6C ) 2 、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又はヘテロアリールであり;
R 6C の各々は、独立して、水素、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又はヘテロアリールであり、2つのR 6C 基が任意にNに結合するとき、2つのR 6C 基は接合してヘテロシクリル又はヘテロアリール環を形成していてもよく;
Gは、−CH 2 −、−CH(R 7 )−、又は−C(R 7 ) 2 −であり;
mは、0、1、2、3、又は4であり;
nは、0、1、2、3、又は4である)
で表される、請求項1に記載の医薬組成物。 - 前記阻害剤が、式:
R 6A の各々は、独立して、ハロゲン、−NO 2 、−CN、−OR 6C 、SR 6C 、N(R 6C ) 2 、−C(=O)R 6C 、−C(=O)OR 6C 、−C(=O)N(R 6C ) 2 、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又はヘテロアリールであり;
R 6C の各々は、独立して、水素、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又はヘテロアリールであり、2つのR 6C 基が任意にNに結合するとき、2つのR 6C 基は接合してヘテロシクリル又はヘテロアリール環を形成していてもよく;
Gは、−CH 2 −、−CH(R 7 )−、又は−C(R 7 ) 2 −であり;
mは、0、1、2、3、又は4であり;
nは、0、1、2、3、又は4である)
で表される、請求項1に記載の医薬組成物。 - 前記阻害剤が、式:
R 6A の各々は、独立して、ハロゲン、−NO 2 、−CN、−OR 6C 、SR 6C 、N(R 6C ) 2 、−C(=O)R 6C 、−C(=O)OR 6C 、−C(=O)N(R 6C ) 2 、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又はヘテロアリールであり;
R 6C の各々は、独立して、水素、アルキル、アルケニル、アルキニル、カルボシクリル、ヘテロシクリル、アリール、又はヘテロアリールであり、2つのR 6C 基が任意にNに結合するとき、2つのR 6C 基は接合してヘテロシクリル又はヘテロアリール環を形成していてもよく;
Gは、−O−、−S−、−NH−、−NR 7 −、−CH 2 −、−CH(R 7 )−、又は−C(R 7 ) 2 −であり;
mは、0、1、2、3、又は4であり;
nは、0、1、2、3、又は4である)
で表される、請求項1に記載の医薬組成物。 - mは0である、請求項7、8及び9のいずれかに記載の医薬組成物。
- 前記患者が、腫瘍又は癌において、対応する正常細胞のバイオマーカーの発現レベルの範囲外の発現レベルを有し、前記バイオマーカーが、
ACSL1、ADORA2B、ADRB1、AMPD3、ARRDC4、BCL2、BCL2A1、CBFβ、CCNA1、CD244、CD44、CDC42EP3、C/EBPα、CECR6、CFLAR、CISH、CSF1、CXCL10、CXCR4、CYTIP、DUSP10、E2F8、EMB、EMR2、ETS1、ETS2、FAM107B、FAM46A、FCER1A、FCGR1B、FLI1、FOG1、FOSL2、GAB2、GAS7、GATA1、GATA2、GFI1B、GMPR、GPR18、GPR183、HBBP1、HEB、HLX、HMGCS1、IGFBP4、IGFBP5、IL17RA、IL1RAP、IPCEF1、IRF1、IRF8、ITGA6、JAG1、LCP2、LDLR、LIMA1、LMO2、LRRC33、LTB、MBP、MICAL2、MYCN、MYO1G、NFE2、NOTCH2、NRP1、P2RY2、PAG1、PLAC8、PLEK、PLXNC1、PMP22、PTPRE、PU.1、PXK、RAB27A、RASA3、RGS16、RHOH、RNF24、RXRA、SELPLG、SLA、SLC7A11、SLC7A5、SOCS1、ST3GAL4、STK17B、TAL1、TIMP3、TMEM104、TNF、TSC22D1、TSC22D3、ZBTB16及びZCCHC5の1つ又は組み合わせである、
請求項1〜10のいずれかに記載の医薬組成物。 - 前記バイオマーカーが、GATA1、GATA2、C/EBPα、FLI1、FOG1、ETS1、PU.1、及びCBFαの1つ又は組み合わせである、請求項1〜10のいずれかに記載の医薬組成物。
- 前記バイオマーカーが、BCL2、CCNA1、CD44、C/EBPα、CBFβ、CSF1、CXCL10、CXCR4、ETS1、ETS2、FLI1、FOG1、FCER1A、GATA1、GATA2、GFI1B、HEB、IRF1、IRF8、JAG1、LMO2、LTB、NFE2、NOTCH2、PU.1、SLA、SOCS1、TAL1、及びTNFの1つ又は組み合わせである、請求項1〜10のいずれかに記載の医薬組成物。
- 前記バイオマーカーが、請求項11〜13のいずれかに記載の群から独立して選択される少なくとも2つである、請求項1〜10のいずれかに記載の医薬組成物。
- 前記バイオマーカーが、請求項11〜13のいずれかに記載の群から独立して選択される少なくとも3つである、請求項1〜10のいずれかに記載の医薬組成物。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562158936P | 2015-05-08 | 2015-05-08 | |
US62/158,936 | 2015-05-08 | ||
US201562187656P | 2015-07-01 | 2015-07-01 | |
US62/187,656 | 2015-07-01 | ||
US201662298352P | 2016-02-22 | 2016-02-22 | |
US62/298,352 | 2016-02-22 | ||
PCT/US2016/031188 WO2016182904A1 (en) | 2015-05-08 | 2016-05-06 | Targeted selection of patients for treatment with cortistatin derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018516884A JP2018516884A (ja) | 2018-06-28 |
JP2018516884A5 true JP2018516884A5 (ja) | 2019-06-13 |
Family
ID=57248502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017557988A Withdrawn JP2018516884A (ja) | 2015-05-08 | 2016-05-06 | コルチスタチン誘導体による治療に対する患者の標的化選択 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20180135134A1 (ja) |
EP (1) | EP3294418A4 (ja) |
JP (1) | JP2018516884A (ja) |
KR (1) | KR20180003597A (ja) |
CN (1) | CN107847763A (ja) |
CA (1) | CA2985203A1 (ja) |
MX (1) | MX2017014338A (ja) |
RU (1) | RU2017142394A (ja) |
WO (1) | WO2016182904A1 (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008092231A1 (en) | 2007-02-01 | 2008-08-07 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
JP5795304B2 (ja) | 2009-03-18 | 2015-10-14 | レスバーロジックス コーポレイション | 新規抗炎症剤 |
EP3268007B1 (en) | 2015-03-13 | 2022-11-09 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
WO2017112823A1 (en) * | 2015-12-23 | 2017-06-29 | President And Fellows Of Harvard College | Targeted selection of patients for treatment with specific cortistatin derivatives |
EP3541408A4 (en) * | 2016-11-15 | 2020-06-24 | The Schepens Eye Research Institute, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ABERRANT ANGIOGENESIS |
US20200224195A1 (en) * | 2016-12-01 | 2020-07-16 | Nestec S.A. | Methods of modulating fam46a |
CN106636408A (zh) * | 2016-12-27 | 2017-05-10 | 北京泱深生物信息技术有限公司 | 一种布加综合征诊断工具 |
JPWO2018159805A1 (ja) | 2017-03-03 | 2020-01-09 | 国立大学法人京都大学 | 膵前駆細胞の製造方法 |
CN108653291A (zh) * | 2017-04-01 | 2018-10-16 | 上海市肿瘤研究所 | Thz1在治疗卵巢癌中的用途 |
US11248054B2 (en) | 2017-06-12 | 2022-02-15 | Bluefin Biomedicine, Inc. | Anti-IL1RAP antibodies and antibody drug conjugates |
JP7416700B2 (ja) | 2017-11-14 | 2024-01-17 | ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド | 増殖性硝子体網膜症および上皮間葉転換と関連付けられる状態の治療のためのrunx1阻害の方法 |
WO2019232467A1 (en) * | 2018-06-01 | 2019-12-05 | President And Fellows Of Harvard College | Pharmacodynamic biomarkers for the treatment of cancer with a cdk8/19 inhibitor |
JP2022542167A (ja) * | 2019-07-26 | 2022-09-29 | ミナ セラピューティクス リミテッド | C/EBPアルファsaRNAを使用する組成物および方法 |
WO2021102420A1 (en) * | 2019-11-22 | 2021-05-27 | The Regents Of The University Of California | Interferon signaling as a cancer biomarker |
JPWO2022107877A1 (ja) | 2020-11-20 | 2022-05-27 | ||
CA3208794A1 (en) | 2021-02-09 | 2022-08-18 | Orizuru Therapeutics, Inc. | Maturation agent |
JPWO2023022200A1 (ja) * | 2021-08-18 | 2023-02-23 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201404596UA (en) * | 2012-02-02 | 2014-10-30 | Senex Biotechnology Inc | Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer |
WO2013122609A1 (en) * | 2012-02-17 | 2013-08-22 | Genentech, Inc. | Methods of using cdk8 antagonists |
WO2014134169A1 (en) * | 2013-02-26 | 2014-09-04 | Senex Biotechnology, Inc. | Inhibitors of cdk8/19 for use in treating estrogen receptor positive breast cancer |
WO2014199377A1 (en) * | 2013-06-10 | 2014-12-18 | Yeda Research And Development Co. Ltd. | Compositions and methods for treating a hematological malignancy associated with an altered runx1 activity or expression |
EA201891279A1 (ru) * | 2013-12-24 | 2019-01-31 | Президент Энд Феллоус Оф Гарвард Колледж | Аналоги кортистатина, их синтез и применения |
WO2017112823A1 (en) * | 2015-12-23 | 2017-06-29 | President And Fellows Of Harvard College | Targeted selection of patients for treatment with specific cortistatin derivatives |
-
2016
- 2016-05-06 RU RU2017142394A patent/RU2017142394A/ru not_active Application Discontinuation
- 2016-05-06 EP EP16793249.0A patent/EP3294418A4/en not_active Withdrawn
- 2016-05-06 WO PCT/US2016/031188 patent/WO2016182904A1/en active Application Filing
- 2016-05-06 KR KR1020177035066A patent/KR20180003597A/ko unknown
- 2016-05-06 MX MX2017014338A patent/MX2017014338A/es unknown
- 2016-05-06 CN CN201680037391.1A patent/CN107847763A/zh active Pending
- 2016-05-06 JP JP2017557988A patent/JP2018516884A/ja not_active Withdrawn
- 2016-05-06 CA CA2985203A patent/CA2985203A1/en not_active Abandoned
-
2017
- 2017-11-08 US US15/807,277 patent/US20180135134A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018516884A5 (ja) | ||
RU2017142394A (ru) | Целевой отбор пациентов для лечения производными кортистатина | |
Nakagawa et al. | Association between high-avidity T-cell receptors, induced by α-fetoprotein− derived peptides, and anti-tumor effects in patients with hepatocellular carcinoma | |
Vieira et al. | Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects | |
Inoda et al. | Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells | |
Jouhi et al. | Different toll-like receptor expression patterns in progression toward cancer | |
Rich et al. | Toll-like receptors and cancer, particularly oral squamous cell carcinoma | |
JP4509018B2 (ja) | 細胞増殖抑制タンパク質及びそれを用いる細胞増殖抑制剤 | |
JP2008200039A5 (ja) | ||
JP2017537627A5 (ja) | ||
JP2016534148A5 (ja) | ||
JP2018509143A5 (ja) | ||
CY1119356T1 (el) | Πυριδινυλ και συντηγμενα παραγωγα πυριδινυλ τριαζολονης | |
JP2016174600A5 (ja) | ||
Liu et al. | Mesenchymal stem cells expressing interleukin-18 suppress breast cancer cells in vitro Corrigendum in/10.3892/etm. 2023.12131 | |
JP2017530171A5 (ja) | ||
JP2013536227A5 (ja) | ||
JP2011137045A5 (ja) | ||
Lyu et al. | Tnfrsf12a-mediated atherosclerosis signaling and inflammatory response as a common protection mechanism of shuxuening injection against both myocardial and cerebral ischemia-reperfusion injuries | |
Puls et al. | YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant | |
JP2018532821A5 (ja) | ||
JP2021504404A5 (ja) | ||
JP2019519593A5 (ja) | ||
JP2020528890A5 (ja) | ||
Vincenzi et al. | Classic Kaposi Sarcoma: to treat or not to treat? |